Ireland's Perrigo Q4 revenue slightly beats

Perrigo

26/02/2026 11:41

Overview

Consumer health product provider's Q4 revenue slightly beat analyst expectations

Adjusted EPS for Q4 missed analyst expectations

Company launching operational enhancement program to deliver $80 mln to $100 mln savings

Outlook

Perrigo sees FY2026 net sales down 5.5% to 1.5%

Perrigo expects FY2026 adjusted EPS of $2.00 to $2.30

Perrigo anticipates CORE FY2026 EPS of $2.25 to $2.55

Result Drivers

INFANT FORMULA IMPACT - Organic net sales decline primarily due to lower sales in infant formula, impacting overall performance

MARKET SHARE GAINS - Despite soft OTC category consumption, Perrigo gained share in store brands and key brands

COST SAVINGS - Project Energize and Supply Chain Reinvention Program delivered significant cost savings, partially offsetting lower gross profit

Company press release: ID:nPn7XvX6Ra

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Sales
Slight Beat*
$1.11 bln
$1.10 bln (3 Analysts)
Q4 Adjusted EPS
Miss
$0.77
$0.79 (3 Analysts)
Q4 EPS
-$10.20
Q4 Adjusted Net Income
Miss
$108 mln
$120.83 mln (3 Analysts)
Q4 Net Income
-$1.41 bln
Q4 Adjusted Operating Income
Miss
$167 mln
$188.53 mln (3 Analysts)

*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the pharmaceuticals peer group is "buy."

Wall Street's median 12-month price target for Perrigo Company PLC is $18.00, about 24.9% above its February 25 closing price of $14.41

The stock recently traded at 5 times the next 12-month earnings vs. a P/E of 7 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)